2018 JSH实践指南:血液恶性肿瘤—淋巴瘤:滤泡性淋巴瘤

2019-06-06 日本血液学会 Int J Hematol. 2019 Jun 6.

2018年日本血液恶性肿瘤指南之滤泡性淋巴瘤管理指南,滤泡性淋巴瘤(FL)是一种惰性B细胞淋巴瘤,本文主要针对FL的诊断,分期,临床管理等内容提出7个临床问题和建议。

中文标题:

2018 JSH实践指南:血液恶性肿瘤—淋巴瘤:滤泡性淋巴瘤

英文标题:

JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma‑1. Follicular lymphoma (FL)

发布机构:

日本血液学会

发布日期:

2019-06-06

简要介绍:

2018年日本血液恶性肿瘤指南之滤泡性淋巴瘤管理指南,滤泡性淋巴瘤(FL)是一种惰性B细胞淋巴瘤,本文主要针对FL的诊断,分期,临床管理等内容提出7个临床问题和建议。 

拓展指南:淋巴瘤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 JSH实践指南:血液恶性肿瘤—淋巴瘤:滤泡性淋巴瘤)] GetToolGuiderByIdResponse(projectId=1, id=4911c1c001ea66eb, title=2018 JSH实践指南:血液恶性肿瘤—淋巴瘤:滤泡性淋巴瘤, enTitle=JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma‑1. Follicular lymphoma (FL), guiderFrom=Int J Hematol. 2019 Jun 6., authorId=null, author=, summary=2018年日本血液恶性肿瘤指南之滤泡性淋巴瘤管理指南,滤泡性淋巴瘤(FL)是一种惰性B细胞淋巴瘤,本文主要针对FL的诊断,分期,临床管理等内容提出7个临床问题和建议。 , cover=, journalId=null, articlesId=null, associationId=1460, associationName=日本血液学会, associationIntro=, copyright=0, guiderPublishedTime=Thu Jun 06 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2018年日本血液恶性肿瘤指南之滤泡性淋巴瘤管理指南,滤泡性淋巴瘤(FL)是一种惰性B细胞淋巴瘤,本文主要针对FL的诊断,分期,临床管理等内容提出7个临床问题和建议。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>淋巴瘤</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=e32421c001ea4263" title="NCCN临床实践指南:B细胞淋巴瘤(2019.V3)" target=_blank>NCCN临床实践指南:B细胞淋巴瘤(2019.V3)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=ac2f71c001ea355e" title="NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2019.V5)" target=_blank>NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2019.V5)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=906611c001e30a62" title="NCCN临床实践指南:霍奇金淋巴瘤(2019.V1)" target=_blank>NCCN临床实践指南:霍奇金淋巴瘤(2019.V1)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=fec3a1c001e211bb" title="NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2019.V4)" target=_blank>NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2019.V4)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=96cab1c001e18756" title="NCCN临床实践指南:B细胞淋巴瘤(2019.V2)" target=_blank>NCCN临床实践指南:B细胞淋巴瘤(2019.V2)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E6%B7%8B%E5%B7%B4%E7%98%A4" target=_blank>有关淋巴瘤更多指南</a></ul>, tagList=[TagDto(tagId=45472, tagName=血液恶性肿瘤), TagDto(tagId=412, tagName=淋巴瘤), TagDto(tagId=10568, tagName=滤泡性淋巴瘤)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11364, appHits=139, showAppHits=0, pcHits=9617, showPcHits=2171, likes=85, shares=4, comments=2, approvalStatus=1, publishedTime=Tue Jun 11 23:24:04 CST 2019, publishedTimeString=2019-06-06, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Jun 11 23:24:04 CST 2019, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 14:19:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 JSH实践指南:血液恶性肿瘤—淋巴瘤:滤泡性淋巴瘤)])
2018 JSH实践指南:血液恶性肿瘤—淋巴瘤:滤泡性淋巴瘤
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=882961, encodeId=6fff88296181, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/7edf10a06ceeb66d2dc97185d14a4d98.jpg, createdBy=12005149020, createdName=雪山一枝梅, createdTime=Sat Sep 05 19:41:53 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367625, encodeId=8b6036e625e1, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Wed Jun 12 06:33:50 CST 2019, time=2019-06-12, status=1, ipAttribution=)]
    2020-09-05 雪山一枝梅

    值得学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=882961, encodeId=6fff88296181, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/7edf10a06ceeb66d2dc97185d14a4d98.jpg, createdBy=12005149020, createdName=雪山一枝梅, createdTime=Sat Sep 05 19:41:53 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367625, encodeId=8b6036e625e1, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Wed Jun 12 06:33:50 CST 2019, time=2019-06-12, status=1, ipAttribution=)]
    2019-06-12 thm112988

    很好

    0